Double-Digit Revenue Growth Driven by Strategic Initiatives Across Industrial and Advanced Solutions
Focused on Driving Margin Expansion
MARLBOROUGH, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the third quarter ended September 30, 2026.
| 截至 9 月 30 日的三个月 | 截至 9 月 30 日的九个月 | |||||||||||||||||||||
| (单位：百万，每股数据和百分比除外） | 2026 | 2025 | 改变 | 2026 | 2025 | 改变 | ||||||||||||||||
| 收入 | $ | 287.5 | $ | 250.8 | 15 | % | $ | 831.6 | $ | 729.3 | 14 | % | ||||||||||
| 毛利率 | 40.7 | % | 39.5 | % | 39.6 | % | 38.7 | % | ||||||||||||||
| 营业收入 | $ | 20.8 | $ | 7.9 | NM | $ | 17.6 | $ | 9.8 | NM | ||||||||||||
| 营业利润率 | 7.2 | % | 3.1 | % | 2.1 | % | 1.3 | % | ||||||||||||||
| 净收入 | $ | 20.3 | $ | 7.5 | 171 | % | $ | 27.1 | $ | 17.8 | 52 | % | ||||||||||
| 稀释后每股收益 | $ | 0.47 | $ | 0.18 | 161 | % | $ | 0.63 | $ | 0.42 | 50 | % | ||||||||||
| 非公认会计准则指标* | ||||||||||||||||||||||
| 经调整毛利率 | 41.0 | % | 39.8 | % | 39.9 | % | 39.2 | % | ||||||||||||||
| 调整后息税折旧及摊销前利润 | $ | 51.5 | $ | 37.0 | 39 | % | $ | 135.2 | $ | 101.2 | 34 | % | ||||||||||
| 经调整的每股摊薄收益 | $ | 0.61 | $ | 0.35 | 74 | % | $ | 1.49 | $ | 0.96 | 55 | % | ||||||||||
*调整后毛利率、调整后息税折旧及摊销前利润（EBITDA）以及调整后每股摊薄收益包含非公认会计原则（Non-GAAP）调整项。本财报中提供了公认会计原则（GAAP）与非公认会计原则指标之间的调节表。
NM - 没有意义。
Management Comments
“We delivered our fourth consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics. “Our performance reflects the strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets. Strong demand for our differentiated welding and additive manufacturing solutions drove growth in Industrial Solutions while disciplined execution of our key strategic initiatives across defense and semiconductor markets led to strong growth in Advanced Solutions. Additionally, I anticipate that our acquisition of Lumibird Medical, which is expected to close in the fourth quarter, will further strengthen our reach, accelerate growth across medical markets, and increase revenue in Advanced Solutions.”
财务要点
| 截至 9 月 30 日的三个月 | 截至 9 月 30 日的九个月 | ||||||||||||||||
| 2026 | 2025 | 改变 | 2026 | 2025 | 改变 | ||||||||||||
| 按应用领域划分的销售额 | |||||||||||||||||
| 工业解决方案 | $ | 239,548 | $ | 214,697 | 12 | % | $ | 704,181 | $ | 607,593 | 16 | % | |||||
| 高级解决方案 | 47,952 | 36,095 | 33 | % | 127,396 | 121,713 | 5 | % | |||||||||
| 总计 | $ | 287,500 | $ | 250,792 | 15 | % | $ | 831,577 | $ | 729,306 | 14 | % | |||||
Third quarter revenue of $288 million increased 15% year over year, driven by 12% growth in Industrial Solutions and 33% growth in Advanced Solutions. Changes in foreign exchange rates increased revenue by approximately 1%. Industrial Solutions sales, accounting for 83% of total revenue, were driven by strong performance in welding and additive manufacturing applications. Advanced Solutions sales improved, driven by higher sales in semiconductor and defense applications. Emerging growth products accounted for 52% of total revenue, down from 58% in the prior quarter due to product mix. By region, sales increased 14% in Asia and 33% in North America and decreased 1% in Europe on a year-over-year basis.
GAAP gross margin of 40.7% and adjusted gross margin of 41.0% increased year over year, driven by lower product costs and $5.0 million in net tariff refunds recorded in the period, partially offset by lower fixed cost absorption. Net income was $20 million, or $0.47 per diluted share, and adjusted EBITDA was $52 million and adjusted earnings per diluted share (EPS) was $0.61 in the third quarter. During the third quarter, IPG generated $46 million in cash flow from operations and spent $17 million on capital expenditures.
业务展望与财务指导
“Our third quarter book-to-bill was approximately one as we continued to see improved industrial demand and executed on our strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers. As we move forward, we remain focused on driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio,” concluded Dr. Gitin.
For the fourth quarter of 2026, IPG expects revenue of $265 million to $295 million, adjusted gross margin between 37.0% and 40.0% and adjusted operating expenses of $91 million to $94 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.30 to $0.60 and adjusted EBITDA in the range of $33 million to $50 million. The guidance assumes no contribution from the acquisition of Lumibird Medical.
As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations and is subject to the risks outlined in the Company's reports filed with the SEC and assumes exchange rates relative to the U.S. dollar of euro 0.88, Japanese yen 157 and Chinese yuan 6.74, respectively.
补充财务信息
Additional supplemental financial information is provided in the unaudited Financial Data Workbook and Third Quarter 2026 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com.
电话会议提醒
The Company will hold a conference call today, November 3, 2026 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com.
联系方式
尤金-费多托夫
投资者关系高级总监
IPG 光子公司
508-597-4713
efedotoff@ipgphotonics.com
关于 IPG 光子公司
Innovation is at the heart of IPG Photonics. As a global leader in laser technology, we apply light to transform the world. From manufacturing to medical and beyond, our breakthrough laser solutions power our customers’ success and expand what's possible. Discover more at www.ipgphotonics.com.
Safe Harbor Statement
Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including those statements related to strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets, the expected timing of the closing of our acquisition of Lumibird Medical and the expectation that the acquisition will increase revenue in Advanced Solutions and strengthen our reach and accelerate growth across medical markets, strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers, driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio, revenue, adjusted gross margin and adjusted operating expenses outlook, adjusted earnings per diluted share and adjusted EBITDA guidance, including the expected impact of tariffs, and the impact of the U.S. dollar on our guidance for the fourth quarter of 2026. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC for the fiscal year ended December 31, 2025), IPG's Quarterly Report on Form 10-Q (filed with the SEC for the quarter ended June 30, 2026), and other reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) |
|||||||||||||
| 截至 9 月 30 日的三个月 | 截至 9 月 30 日的九个月 | ||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||
| (单位：千，每股数据除外） | |||||||||||||
| 净销售额 | $ | 287,500 | $ | 250,792 | $ | 831,577 | $ | 729,306 | |||||
| 销售成本 | 170,446 | 151,787 | 502,500 | 446,916 | |||||||||
| 毛利润 | 117,054 | 99,005 | 329,077 | 282,390 | |||||||||
| 运营开支 | |||||||||||||
| 销售和营销 | 23,934 | 23,771 | 72,286 | 73,753 | |||||||||
| 研发 | 31,335 | 30,358 | 95,648 | 88,631 | |||||||||
| 一般事务和行政 | 37,502 | 35,092 | 110,139 | 102,782 | |||||||||
| 诉讼事项的解决 | - | - | 13,334 | - | |||||||||
| 减值损失 | 231 | - | 17,805 | - | |||||||||
| 重组费用 | - | 425 | - | 425 | |||||||||
| 汇兑损失 | 3,275 | 1,504 | 2,293 | 7,013 | |||||||||
| 运营支出总额 | 96,277 | 91,150 | 311,505 | 272,604 | |||||||||
| 营业收入 | 20,777 | 7,855 | 17,572 | 9,786 | |||||||||
| 其他收入，净额 | |||||||||||||
| 利息收入净额 | 7,688 | 7,283 | 21,720 | 22,728 | |||||||||
| Other (expense) income, net | (50 | ) | 516 | 2,683 | 2,026 | ||||||||
| 其他收入共计 | 7,638 | 7,799 | 24,403 | 24,754 | |||||||||
| 所得税费用前的利润 | 28,415 | 15,654 | 41,975 | 34,540 | |||||||||
| 所得税准备金 | 8,142 | 8,191 | 14,876 | 16,714 | |||||||||
| 净收入 | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | |||||
| 每股普通股净利润： | |||||||||||||
| 基本 | $ | 0.48 | $ | 0.18 | $ | 0.64 | $ | 0.42 | |||||
| 稀释 | $ | 0.47 | $ | 0.18 | $ | 0.63 | $ | 0.42 | |||||
| 已发行普通股加权平均数： | |||||||||||||
| 基本 | 42,531 | 42,199 | 42,416 | 42,427 | |||||||||
| 稀释 | 42,840 | 42,556 | 42,904 | 42,659 | |||||||||
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) |
||||||||
| 9月30日 | 12 月 31 日 | |||||||
| 2026 | 2025 | |||||||
| (In thousands, except share data) | ||||||||
| 资产 | ||||||||
| 流动资产 | ||||||||
| 现金及现金等价物 | $ | 710,688 | $ | 403,790 | ||||
| 短期投资 | 215,304 | 435,538 | ||||||
| 应收账款，净额 | 191,150 | 181,734 | ||||||
| 库存 | 337,890 | 313,416 | ||||||
| 预付所得税 | 33,145 | 43,196 | ||||||
| 预付费用和其他流动资产 | 54,460 | 45,766 | ||||||
| 流动资产共计 | 1,542,637 | 1,423,440 | ||||||
| 长期投资 | - | 76,533 | ||||||
| 递延所得税净额 | 122,235 | 123,889 | ||||||
| 商誉 | 70,281 | 71,735 | ||||||
| 无形资产，净额 | 42,777 | 49,933 | ||||||
| 财产、厂房和设备，净额 | 648,326 | 637,516 | ||||||
| 其他资产 | 45,787 | 41,234 | ||||||
| 总资产 | $ | 2,472,043 | $ | 2,424,280 | ||||
| 负债和权益 | ||||||||
| 流动负债 | ||||||||
| 应付账款 | $ | 48,782 | $ | 39,288 | ||||
| 应计费用和其他流动负债 | 204,874 | 184,849 | ||||||
| 应付所得税 | 3,858 | 9,900 | ||||||
| 流动负债共计 | 257,514 | 234,037 | ||||||
| 其他长期负债和递延所得税 | 59,581 | 62,113 | ||||||
| 负债总额 | 317,095 | 296,150 | ||||||
| 承付款和或有事项 | ||||||||
| 股东权益： | ||||||||
| Common stock, $0.0001 par value, 175,000,000 shares authorized; 57,380,668 and 42,508,140 shares issued and outstanding, respectively, at September 30, 2026; 56,964,939 and 42,127,067 shares issued and outstanding, respectively, at December 31, 2025. |
6 | 6 | ||||||
| Treasury stock, at cost, 14,872,528 and 14,837,872 shares held at September 30, 2026 and December 31, 2025, respectively. |
(1,558,277 | ) | (1,555,629 | ) | ||||
| 额外实收资本 | 1,097,673 | 1,077,172 | ||||||
| 留存收益 | 2,672,063 | 2,644,964 | ||||||
| 累计其他综合损失 | (56,517 | ) | (38,383 | ) | ||||
| 股东权益总额 | 2,154,948 | 2,128,130 | ||||||
| 负债和股东权益总额 | $ | 2,472,043 | $ | 2,424,280 | ||||
| IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) |
||||||||
| 截至 9 月 30 日的九个月 | ||||||||
| 2026 | 2025 | |||||||
| （单位：千） | ||||||||
| 经营活动产生的现金流量 | ||||||||
| 净收入 | $ | 27,099 | $ | 17,826 | ||||
| 将净收入与运营活动提供的净现金进行调节： | ||||||||
| 折旧和摊销 | 47,377 | 46,799 | ||||||
| 减值损失 | 17,805 | - | ||||||
| 库存、保修和坏账准备金 | 33,594 | 31,766 | ||||||
| 其他 | 25,081 | 21,119 | ||||||
| Changes in assets and liabilities that provided (used) cash: | ||||||||
| 应收账款和应付账款 | 1,535 | 18,787 | ||||||
| 库存 | (60,189 | ) | (52,005 | ) | ||||
| 其他 | (13,771 | ) | (37,757 | ) | ||||
| 业务活动提供的现金净额 | 78,531 | 46,535 | ||||||
| 投资活动产生的现金流量 | ||||||||
| 不动产、厂房和设备购置及押金 | (54,437 | ) | (60,907 | ) | ||||
| 出售不动产、厂房和设备的收益 | 2,204 | 605 | ||||||
| 投资的购入 | (360,732 | ) | (866,402 | ) | ||||
| Purchases of equity investment | (8,000 | ) | - | |||||
| 投资到期所得款项 | 663,124 | 633,731 | ||||||
| 从买方收到的、用于待售资产的定金 | 2,000 | - | ||||||
| 其他 | 111 | 69 | ||||||
| 投资活动提供（使用）的现金净额 | 244,270 | (292,904 | ) | |||||
| 筹资活动产生的现金流量 | ||||||||
| Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock under employee stock option and purchase plans |
(11,053 | ) | (4,316 | ) | ||||
| 购买库存股（扣除消费税后的成本） | (2,648 | ) | (46,603 | ) | ||||
| 融资活动所用现金净额 | (13,701 | ) | (50,919 | ) | ||||
| 汇率变动对现金、现金等价物及待售现金的影响 | (1,727 | ) | 23,274 | |||||
| Net increase (decrease) in cash, cash equivalents and cash held for sale | 307,373 | (274,014 | ) | |||||
| 现金及现金等价物 - 期初 | 403,790 | 620,040 | ||||||
| 现金、现金等价物及持作出售的现金 — 期末 | $ | 711,163 | $ | 346,026 | ||||
| 现金流信息的补充披露： | ||||||||
| 支付利息的现金 | $ | 54 | $ | 136 | ||||
| 已支付的所得税款（扣除退税后的净额） | $ | 9,273 | $ | 44,258 | ||||
| IPG 光子技术公司 非美国通用会计准则财务指标补充明细表（未经审计） |
||||||||
非美国通用会计准则调整后财务信息的使用
We refer to certain financial measures that are not recognized under United States generally accepted accounting principles (“GAAP”) and are provided as supplemental information to enhance understanding of the Company’s financial performance. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measure presented by the Company. The following information provides the definition of adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted net earnings per share (EPS), and adjusted tax rate as presented, which are financial measures that are not calculated or presented in accordance with GAAP, and reconciliation to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and an adjusted tax rate as supplemental information and in addition to the financial measures presented by the Company that are calculated and presented in accordance with GAAP.
We define adjusted gross profit as reported gross profit, adjusted for non-recurring, infrequent, or unusual charges, including acquisition and integration charges and amortization of acquisition-related intangibles.
我们将调整后毛利率定义为调整后毛利润除以总收入。
We define adjusted operating expense and resultant adjusted operating income as reported operating expenses and resultant operating income, adjusted for non-recurring, infrequent, or unusual charges, including impairment charges, settlement and fees of litigation matters, restructuring charges, acquisition and integration charges, amortization of acquisition-related intangibles, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.
我们将EBITDA定义为净利润加上利息支出（收入）、所得税费用、折旧费用和摊销费用。
We define adjusted EBITDA as EBITDA adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including stock-based compensation, restructuring charges, impairment charges, settlement and fees of litigation matters, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.
We define adjusted net income as reported net income, adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including impairment charges, settlement and fees of litigation matters, restructuring charges, amortization of acquisition-related intangibles, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture, certain discrete tax items and non-GAAP income tax reconciling adjustments.
我们将调整后每股收益定义为：调整后净利润除以加权平均稀释流通股数。
我们将“调整后税率”定义为：根据一般公认会计原则（GAAP）计算的税率，经一次性税务项目及非GAAP调整项的净影响调整后得出的数值。
管理层认为，这些非公认会计原则财务指标为评估各期间的经营业绩提供了额外依据。具体而言，通过剔除某些非现金支出及其他项目，这些非公认会计原则财务指标为管理层提供了额外的手段，以理解和评估本公司持续经营业务的经营成果及趋势；管理层认为，若不进行此类剔除，可能会增加本公司持续经营业务与前期数据进行比较的难度，掩盖持续经营业务的趋势，或削弱管理层作出有效预测的能力。
In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors. However, these non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies. Management may, however, utilize other measures to illustrate performance in the future. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided below. These non-GAAP measures exclude (i) amortization of acquisition-related intangibles, (ii) restructuring charges, (iii) acquisition and integration costs, (iv) impairment charges, (v) foreign exchange gains/losses, (vi) interest income, (vii) benefit (provision) from income taxes, (viii) depreciation, (ix) amortization, (x) stock-based compensation, (xi) gain/loss on disposal of assets/divestiture, (xii) settlement and fees of litigation matters, (xiii) certain discrete tax items, and (xiv) non-GAAP income tax reconciling adjustments.
我们未就前瞻性非公认会计原则（Non-GAAP）调整后每股摊薄收益及调整后息税折旧摊销前利润（EBITDA）与其最直接可比的公认会计原则（GAAP）财务指标提供定量调节表，原因是若不付出不合理的努力，我们无法以合理的确定性估计某些重大项目的最终发生时间或金额。 这是由于预测可能影响调整后每股摊薄收益及调整后息税折旧摊销前利润的各项项目的发生时间及/或金额存在固有难度。此类项目包括尚未发生、超出本公司控制范围、无法合理预测及/或不会产生任何实质性调整或差异的项目。基于相同原因，本公司无法说明该缺失信息可能具有的重大性。
Our non-GAAP tax provision for the fiscal third quarter of 2026 is 23%. The difference between our GAAP income tax provision and our non-GAAP income tax provision is presented as non-GAAP income tax reconciling adjustments.
| IPG PHOTONICS CORPORATION SUPPLEMENTAL SCHEDULE OF NON-GAAP MEASURES (UNAUDITED) |
||||||||||||||||
| 毛利与调整后毛利、调整后毛利率的调节表 | ||||||||||||||||
| 截至 9 月 30 日的三个月 | 截至 9 月 30 日的九个月 | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| （单位：千，百分比除外） | ||||||||||||||||
| 毛利润 | $ | 117,054 | $ | 99,005 | $ | 329,077 | $ | 282,390 | ||||||||
| 毛利率 | 40.7 | % | 39.5 | % | 39.6 | % | 38.7 | % | ||||||||
| 与收购相关的无形资产摊销 | 720 | 851 | 2,360 | 2,928 | ||||||||||||
| 收购及整合费用 | - | - | - | 482 | ||||||||||||
| 调整后的毛利润 | $ | 117,774 | $ | 99,856 | $ | 331,437 | $ | 285,800 | ||||||||
| 经调整毛利率 | 41.0 | % | 39.8 | % | 39.9 | % | 39.2 | % | ||||||||
Reconciliation of Operating Expenses to Adjusted Operating Expenses
| 截至 9 月 30 日的三个月 | 截至 9 月 30 日的九个月 | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| （单位：千） | ||||||||||||
| Operating expenses | $ | 96,277 | $ | 91,150 | $ | 311,505 | $ | 272,604 | ||||
| Less: | ||||||||||||
| 与收购相关的无形资产摊销 | 1,231 | 1,551 | 3,701 | 4,570 | ||||||||
| 收购及整合费用 | 151 | 246 | 987 | 1,823 | ||||||||
| 减值损失 | 231 | - | 17,805 | - | ||||||||
| 重组费用 | 149 | 425 | 500 | 425 | ||||||||
| 诉讼案件的和解与费用 | - | - | 14,435 | - | ||||||||
| 汇兑损失 | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||
| Adjusted operating expenses | $ | 91,240 | $ | 87,424 | $ | 271,784 | $ | 258,773 | ||||
Reconciliation of Operating Income to Adjusted Operating Income
| 截至 9 月 30 日的三个月 | 截至 9 月 30 日的九个月 | |||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||
| （单位：千） | ||||||||||||
| 营业收入 | $ | 20,777 | $ | 7,855 | $ | 17,572 | $ | 9,786 | ||||
| 与收购相关的无形资产摊销 | 1,951 | 2,402 | 6,061 | 7,498 | ||||||||
| 收购及整合费用 | 151 | 246 | 987 | 2,305 | ||||||||
| 减值损失 | 231 | - | 17,805 | - | ||||||||
| 重组费用 | 149 | 425 | 500 | 425 | ||||||||
| 诉讼案件的和解与费用 | - | - | 14,435 | - | ||||||||
| 汇兑损失 | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||
| 经调整的营业收入 | $ | 26,534 | $ | 12,432 | $ | 59,653 | $ | 27,027 | ||||
净利润与调整后息税折旧及摊销前利润的调节表
| 截至 9 月 30 日的三个月 | 截至 9 月 30 日的九个月 | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| （单位：千） | ||||||||||||||||
| 净收入 | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | ||||||||
| 利息收入净额 | (7,688 | ) | (7,283 | ) | (21,720 | ) | (22,728 | ) | ||||||||
| 所得税准备金 | 8,142 | 8,191 | 14,876 | 16,714 | ||||||||||||
| 折旧 | 12,986 | 12,392 | 38,447 | 36,120 | ||||||||||||
| 摊销 | 2,976 | 3,240 | 8,930 | 10,679 | ||||||||||||
| 息税折旧及摊销前利润 | $ | 36,689 | $ | 24,003 | $ | 67,632 | $ | 58,611 | ||||||||
| 减值损失 | 231 | - | 17,805 | - | ||||||||||||
| 股权激励 | 11,022 | 10,780 | 31,597 | 32,834 | ||||||||||||
| 重组费用 | 149 | 425 | 500 | 425 | ||||||||||||
| 收购及整合费用 | 151 | 246 | 987 | 2,305 | ||||||||||||
| 诉讼案件的和解与费用 | - | - | 14,435 | - | ||||||||||||
| 汇兑损失 | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||||||
| 调整后息税折旧及摊销前利润 | $ | 51,517 | $ | 36,958 | $ | 135,249 | $ | 101,188 | ||||||||
公认会计原则（GAAP）与非公认会计原则（Non-GAAP）净利润的调节表，以及公认会计原则（GAAP）与非公认会计原则（Non-GAAP）每股净利润（摊薄）的调节表
| 截至 9 月 30 日的三个月 | 截至 9 月 30 日的九个月 | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| （单位：千，每股数据除外） | ||||||||||||||||
| 净收入 | $ | 20,273 | $ | 7,463 | $ | 27,099 | $ | 17,826 | ||||||||
| 减值损失 | 231 | - | 17,805 | - | ||||||||||||
| 与收购相关的无形资产摊销 | 1,951 | 2,402 | 6,061 | 7,498 | ||||||||||||
| 重组费用 | 149 | 425 | 500 | 425 | ||||||||||||
| 收购及整合费用 | 151 | 246 | 987 | 2,305 | ||||||||||||
| 诉讼案件的和解与费用 | - | - | 14,435 | - | ||||||||||||
| 汇兑损失 | 3,275 | 1,504 | 2,293 | 7,013 | ||||||||||||
| 某些单独列示的税务项目 | 949 | 3,414 | 84 | 8,303 | ||||||||||||
| 非公认会计原则调整的税务影响 | (711 | ) | (613 | ) | (5,337 | ) | (2,471 | ) | ||||||||
| 经调整净利润 | $ | 26,268 | $ | 14,841 | $ | 63,927 | $ | 40,899 | ||||||||
| 经调整的每股摊薄净利润 | $ | 0.61 | $ | 0.35 | $ | 1.49 | $ | 0.96 | ||||||||
| 加权平均稀释后流通股 | 42,840 | 42,556 | 42,904 | 42,659 | ||||||||||||
公认会计原则（GAAP）与非公认会计原则（Non-GAAP）有效税率的调节表
| 截至 9 月 30 日的三个月 | 截至 9 月 30 日的九个月 | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| 税率 | 29 | % | 52 | % | 35 | % | 48 | % | ||||||||
| 单独列示的税项 | (3 | ) | % | (22 | ) | % | - | % | (24 | ) | % | |||||
| 非公认会计原则调整的净影响 | (3 | ) | % | (3 | ) | % | (11 | ) | % | (3 | ) | % | ||||
| 调整后税率 | 23 | % | 27 | % | 24 | % | 21 | % | ||||||||
